Journal article icon

Journal article

Compensation for cures: Why we should pay a premium for participation in ‘challenge studies’

Abstract:

Antibiotic resistance is one of the most pressing public health problems humanity faces. Research into new classes of antibiotics and new kinds of treatments – including risky experimental treatments such as phage therapy and vaccines – is an important part of improving our ability to treat infectious diseases. In order to aid this research, we will argue that we should permit researchers to pay people any amount of money to compensate for the risks of participating in clinical trials, includ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1111/bioe.12596

Authors


More by this author
Institution:
University of Oxford
Division:
HUMS
Department:
Philosophy Faculty
Oxford college:
St Cross College
Role:
Author
Publisher:
Wiley Publisher's website
Journal:
Bioethics Journal website
Publication date:
2019-05-28
Acceptance date:
2019-03-22
DOI:
EISSN:
1467-8519
ISSN:
0269-9702
Source identifiers:
984456
Keywords:
Pubs id:
pubs:984456
UUID:
uuid:4e5ae0de-3d24-4f4d-a9cd-e7c8dd2653b9
Local pid:
pubs:984456
Deposit date:
2019-03-26

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP